Overview

• The company sold 7.9 million shares at $19 each with underwriters granted an option to purchase up to 1.185 million additional shares
• Shares opened at $23 on June 6, a 21% jump from the IPO price, and reached an intraday high of $28
• The debut made Omada the second major digital health firm to go public in 2025 following Hinge Health
• First-quarter revenue rose 57% year over year to $55 million while net loss narrowed to $9.4 million
• Founded in 2012, Omada provides virtual care for chronic conditions and partners with employers and pharmacy benefit managers such as CVS and Cigna